|
|
40
|
|
|
4981D
|
|
|
DACARBAZINE 200MG INJ (CIP/AHI)
|
|
|
DACARBAZINE
|
|
|
DACARBAZINE
|
|
|
200MG VIAL
|
|
|
BQ
|
|
|
23.02
|
|
|
23.02
|
|
|
200MG
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
CIP
|
|
|
CIPLA LTD
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|